2012-08-14
| Signal | Price | Bias | Subject | Owned |
|---|---|---|---|---|
| BUY | $52.930 | CAUTIOUS | NORTH AMERICAN & ETFs | No |
Have just changed CEOs so there is a bit of integration going on. Still about 40% exposed to Europe, which weighs on the stock on an ongoing basis. Have a lot of revenue drivers going forward. In an area called Enterprise Content Management and have done a good job here.Have just changed CEOs so there is a bit of integration going on. Still about 40% exposed to Europe, which weighs on the stock on an ongoing basis. Have a lot of revenue drivers going forward. In an area called Enterprise Content Management and have done a good job here.
Mike S. Newton, CIM FCSI
Portfolio Manager, Director, Wealth Management,
ScotiaMcleod, The Newton Group http://www.newtongroupwealth.com/
December 27th 2012 at 1:04pm
OTC ( OTEX on Nasdaq) : Exposure to Europe could well be an advantage. I did not plough through detailed filings. Its strategy as articulated in MDA as filed makes much sense. Appears to be well run although I don’t know the inner workings. I see that Raymond James Canada has picked OTC as one of its best picks for 2013. [Disclosure: I have a small position in OTC and I do not plan to sell in the next 3 plus months nor do I plan to add to the position in less than one month]
You must be logged in to comment.